Press play above for something supernatural from Bonython. *** Don't miss another headline from SURFER! Subscribe to our newsletter, follow us on Instagram, and stay connected with the latest ...
(RTTNews) - Shares of Supernus Pharmaceuticals Inc. (SUPN) are down over 20% in premarket trading Wednesday, following disappointing results from a Phase 2b study of SPN-820 in adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback